• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tiziana Life Sciences Ltd - Common Shares (NQ:TLSA)

    1.950 -0.020 (-1.02%)
    Streaming Delayed Price Updated: 11:42 AM EDT, Oct 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 94,533
    Open 1.950
    Bid (Size) 1.940 (46)
    Ask (Size) 1.960 (2)
    Prev. Close 1.970
    Today's Range 1.910 - 2.000
    52wk Range 0.6302 - 2.600
    Shares Outstanding 194,612,289
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Stock Rises On Advancing Second Asset Besides Foralumab: Retail Thinks Stock Has ‘So Much Potential’
    Via Stocktwits

    Performance

    YTD
    +186.4%
    +186.4%
    1 Month
    +20.4%
    +20.4%
    3 Month
    +27.5%
    +27.5%
    6 Month
    +116.6%
    +116.6%
    1 Year
    +111.5%
    +111.5%

    More News

    Read More
    Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces Purchase of Shares by Chairman
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Lucid Is Now Shipping Adapters That Let Customers Access Elon Musk-Led Tesla's Supercharger Network
    Via Benzinga
    Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences to Present at the Bio International Convention
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Uber Stock Ready to Ride Higher on Waymo Partnership
    Via MarketBeat
    Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces Purchase of Shares by Chairman
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Tiziana Life Sciences Ltd - Common Shares publicly traded?
    Yes, Tiziana Life Sciences Ltd - Common Shares is publicly traded.
    What exchange does Tiziana Life Sciences Ltd - Common Shares trade on?
    Tiziana Life Sciences Ltd - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Tiziana Life Sciences Ltd - Common Shares?
    The ticker symbol for Tiziana Life Sciences Ltd - Common Shares is TLSA on the Nasdaq Stock Market
    What is the current price of Tiziana Life Sciences Ltd - Common Shares?
    The current price of Tiziana Life Sciences Ltd - Common Shares is 1.950
    When was Tiziana Life Sciences Ltd - Common Shares last traded?
    The last trade of Tiziana Life Sciences Ltd - Common Shares was at 10/07/25 11:42 AM ET
    What is the market capitalization of Tiziana Life Sciences Ltd - Common Shares?
    The market capitalization of Tiziana Life Sciences Ltd - Common Shares is 379.49M
    How many shares of Tiziana Life Sciences Ltd - Common Shares are outstanding?
    Tiziana Life Sciences Ltd - Common Shares has 379M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.